09.07.2015

Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.

08.01.2015

 SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone Clear™.

01.11.2015

SonoMotion reaches agreement with the University of Washington for exclusive license to an extensive IP portfolio related to Break Wave™ and Stone Clear™.

05.19.2015

 Positive First-In-Man Stone Clear™ clinical trial results presented at the American Urological Association (AUA) meeting in New Orleans.

10.24.2014

SonoMotion brings onboard Dr. Oren Levy as its Chief Executive Officer and Chairman of the Board.